- US12281127utility2025Pyrido[4,3-d]pyrimidine Compounds0 cites
- US12269896utility2025Antibodies Specific for Gucy2c and Uses Thereof0 cites
- US12247022utility2025Combinations for Treatment of NASH/NAFLD and Related Diseases0 cites
- US12234259utility2025Glycoconjugation Process0 cites
- USD1063100design2025Diagnostic Device with Led Display0 cites
- US12227507utility2025Pharmaceutical Compounds0 cites
- US12227564utility2025Anti-gdf15 Antibodies, Compositions and Methods of Use0 cites
- USD1060387design2025Display Screen or Portion Thereof with Graphical User Interface0 cites
- US12208389utility2025Multiplexed Biological Assay Device with Electronic Readout0 cites
- US12202836utility2025Bicyclic-fused Heteroaryl or Aryl Compounds0 cites
- US12202910utility2025Antibodies Specific for FLT3 and Their Uses0 cites
- US12187727utility2025Methods for Antagonizing a Melanocortin 4 Receptor0 cites
- USD1055702design2024Pharmaceutical Product Container0 cites
- US12178803utility2024CD47 Blockade with PARP Inhibition for Disease Treatment0 cites
- US12168698utility2024Tissue Factor Pathway Inhibitor Antibodies and Uses Thereof0 cites
- US12152081utility2024Chimeric Antigen Receptors Targeting CD700 cites
- US12138302utility2024Escherichia Coli Compositions and Methods Thereof0 cites
- US12128095utility2024Escherichia Coli Compositions and Methods Thereof0 cites
- US12129256utility2024Pyrazolo[1,5-a]pyrazin-4-yl Derivatives0 cites